{
    "2020-05-18": [
        [
            {
                "time": "",
                "original_text": "一年内已连下4城：偏爱CRO和骨科的高瓴资本盯上开立医疗",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "CRO",
                        "骨科",
                        "开立医疗"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业的投资江湖再度迎来重磅消息",
                "features": {
                    "keywords": [
                        "医药行业",
                        "投资",
                        "重磅消息"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：化药注射剂一致性评价启动",
                "features": {
                    "keywords": [
                        "医药生物",
                        "化药注射剂",
                        "一致性评价"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "定增进行时：薅上市公司羊毛，顶级PE机构的PK开始了",
                "features": {
                    "keywords": [
                        "定增",
                        "PE机构",
                        "上市公司"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "投资"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "",
                "original_text": "医药行业投资江湖再度迎来重磅消息 明星机构搅动医药板块",
                "features": {
                    "keywords": [
                        "医药行业",
                        "投资",
                        "明星机构",
                        "医药板块"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "江湖风起，知名投资机构在生物医药领域密集落子",
                "features": {
                    "keywords": [
                        "投资机构",
                        "生物医药",
                        "密集落子"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "17股获券商买入评级，会畅通讯目标涨幅达101.35%",
                "features": {
                    "keywords": [
                        "券商",
                        "买入评级",
                        "会畅通讯",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "通信"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "投资布局 密集落子 明星机构搅动医药板块",
                "features": {
                    "keywords": [
                        "投资布局",
                        "明星机构",
                        "医药板块"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "投资布局 明星机构搅动医药板块",
                "features": {
                    "keywords": [
                        "投资布局",
                        "明星机构",
                        "医药板块"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}